Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03664804
Recruitment Status : Completed
First Posted : September 11, 2018
Last Update Posted : October 27, 2021
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 7, 2021
Actual Study Completion Date : May 7, 2021